hairpin RNAs and the eﬀect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev., 13, 83–105. 37. Blidner,R.A., Hammer,R.P., Lopez,M.J., Robinson,S.O. and Monroe,W.T. (2007) Fully 20-deoxy-20-ﬂuoro substituted nucleic acids induce RNA interference in mammalian cell culture. Chem. Biol. Drug Des., 70, 113–122. 38. Morrissey,D.V., Lockridge,J.A., Shaw,L., Blanchard,K., Jensen,K., Breen,W., Hartsough,K., Machemer,L., Radka,S., Jadhav,V. et al. (2005) Potent and persistent in vivo anti-HBV activity of chemically modiﬁed siRNAs. Nat. Biotech., 23, 1002–1007. 39. Hornung,V., Ellegast,J., Kim,S., Brzozka,K., Jung,A., Kato,H., Poeck,H., Akira,S., Conzelmann,K.-K., Schlee,M. et al. (2006) 50-Triphosphate RNA Is the Ligand for RIG-I. Science, 314, 994–997. 40. Zamanian-Daryoush,M., Marques,J.T., Gantier,M.P., Behlke,M.A., John,M., Rayman,P., Finke,J. and Williams,B.R.G. (2008) Determinants of cytokine induction by small interfering RNA in human peripheral blood mononuclear cells. J. Interferon Cytokine Res., 28, 221–233. 41. Czauderna,F., Fechtner,M., Dames,S., Aygun,H., Klippel,A., Pronk,G.J., Giese,K. and Kaufmann,J. (2003) Structural variations and stabilising modiﬁcations of synthetic siRNAs in mammalian cells. Nucleic Acids Res., 31, 2705–2716. 42. Collingwood,M.A., Rose,S.D., Huang,L., Hillier,C., Amarzguioui,M., Wiiger,M.T., Soifer,H.S., Rossi,J.J. and Behlke,M.A. (2008) Chemical modiﬁcation patterns compatible with high potency dicer-substrate small interfering RNAs. Oligonucleotides, 18, 187–200. 43. Judge,A.D., Bola,G., Lee,A.C.H. and MacLachlan,I. (2006) Design of noninﬂammatory synthetic siRNA mediating potent gene silencing in vivo. Mol. Ther., 13, 494–505. 44. Robbins,M., Judge,A., Liang,L., McClintock,K., Yaworski,E. and MacLachlan,I. (2007) 20-O-Methyl-modiﬁed RNAs act as TLR7 antagonists. Mol. Ther., 15, 1663–1669. 45. Cekaite,L., Furset,G., Hovig,E. and Sioud,M. (2007) Gene expression analysis in blood cells in response to unmodiﬁed and 20-modiﬁed siRNAs reveals TLR-dependent and independent eﬀects. J. Mol. Biol., 365, 90–108. 46. Koshkin,A.A., Singh,S.K., Nielsen,P., Rajwanshi,V.K., Kumar,R., Meldgaard,M., Olsen,C.E. and Wengel,J. (1998) LNA (Locked Nucleic Acids): Synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition. Tetrahedron, 54, 3607–3630. 47. Obika,S., Nanbu,D., Hari,Y., Andoh,J.-i., Morio,K.-i., Doi,T. and Imanishi,T. (1998) Stability and structural features of the duplexes containing nucleoside analogues with a ﬁxed N-type conformation, 20-O,40-C-methyleneribonucleosides. Tetrahedron Lett., 39, 5401–5404. 48. Petersen,M. and Wengel,J. (2003) LNA: a versatile tool for therapeutics and genomics. Trends Biotechnol., 21, 74–81. 49. Braasch,D.A. and Corey,D.R. (2001) Locked nucleic acid (LNA): ﬁne-tuning the recognition of DNA and RNA. Chem. Biol., 8, 1–7. 50. Wahlestedt,C., Salmi,P., Good,L., Kela,J., Johnsson,T., Hokfelt,T., Broberger,C., Porreca,F., Lai,J., Ren,K. et al. (2000) Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc. Natl Acad. Sci. USA, 97, 5633–5638. 51. Elmen,J., Thonberg,H., Ljungberg,K., Frieden,M., Westergaard,M., Xu,Y., Wahren,B., Liang,Z., Urum,H., Koch,T. et al. (2005) Locked nucleic acid (LNA) mediated improvements Nucleic Acids Research, 2010, Vol. 38, No. 15 5259 in siRNA stability and functionality. Nucleic Acids Res., 33, 439–447. 52. Mook,O.R., Baas,F., de Wissel,M.B. and Fluiter,K. (2007) Evaluation of locked nucleic acid-modiﬁed small interfering RNA in vitro and in vivo. Mol. Cancer Therap., 6, 833–843. 53. Hornung,V., Guenthner-Biller,M., Bourquin,C., Ablasser,A., Schlee,M., Uematsu,S., Noronha,A., Manoharan,M., Akira,S., de Fougerolles,A. et al. (2005) Sequence-speciﬁc potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat. Med., 11, 263–270. 54. Allerson,C.R., Siouﬁ,N., Jarres,R., Prakash,T.P., Naik,N., Berdeja,A., Wanders,L., Griﬀey,R.H., Swayze,E.E. and Bhat,B. (2005) Fully 20-modiﬁed oligonucleotide duplexes with improved in vitro potency and stability compared to unmodiﬁed small interfering RNA. J. Med. Chem., 48, 901–904. 55. Koller,E., Propp,S., Murray,H., Lima,W., Bhat,B., Prakash,T.P., Allerson,C.R., Swayze,E.E., Marcusson,E.G. and Dean,N.M. (2006) Competition for RISC binding predicts in vitro potency of siRNA. Nucleic Acids Res., 34, 4467–4476. 56. Dande,P., Prakash,T.P., Siouﬁ,N., Gaus,H., Jarres,R., Berdeja,A., Swayze,E.E., Griﬀey,R.H. and Bhat,B. (2006) Improving RNA interference in mammalian cells by 40-thio-modiﬁed small interfering RNA (siRNA): eﬀect on siRNA activity and nuclease stability when used in combination with 20-O-alkyl Modiﬁcations. J. Med. Chem., 49, 1624–1634. 57. Holen,T., Amarzguioui,M., Babaie,E. and Prydz,H. (2003) Similar behaviour of single-strand and double-strand siRNAs suggests they act through a common RNAi pathway. Nucleic Acids Res., 31, 2401–2407. 58. Amarzguioui,M., Holen,T., Babaie,E. and Prydz,H. (2003) Tolerance for mutations and chemical modiﬁcations in a siRNA. Nucleic Acids Res., 31, 589–595. 59. Janowski,B.A., Kaihatsu,K., Huﬀman,K.E., Schwartz,J.C., Ram,R., Hardy,D., Mendelson,C.R. and Corey,D.R. (2005) Inhibiting transcription of chromosomal DNA with antigene peptide nucleic acids. Nat. Chem. Biol., 1, 210–215. 60. Beane,R.L., Ram,R., Gabillet,S., Arar,K., Monia,B.P. and Corey,D.R. (2007) Inhibiting gene expression with locked nucleic acids (LNAs) that target chromosomal DNA. Biochemistry, 46, 7572–7580. 61. Hu,J. and Corey,D.R. (2007) Inhibiting gene expression with peptide nucleic acid (PNA)-peptide conjugates that target chromosomal DNA. Biochemistry, 46, 7581–7589. 62. Nielsen,P.E., Egholm,M., Berg,R.H. and Buchardt,O. (1991) Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science, 254, 1497–1500. 63. Egholm,M., Buchardt,O., Christensen,L., Behrens,C., Freier,S.M., Driver,D.A., Berg,R.H., Kim,S.K., Norden,B. and Nielsen,P.E. (1993) PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature, 365, 566–568. 64. Giovannangeli,C., Diviacco,S., Labrousse,V., Gryaznov,S., Charneau,P. and Helene,C. (1997) Accessibility of nuclear DNA to triplex-forming oligonucleotides: the integrated HIV-1 provirus as a target. Proc. Natl Acad. Sci. USA, 94, 79–84. 65. Larsen,H.J. and Nielsen,P.E. (1996) Transcription-mediated binding of peptide nucleic acid (PNA) to double-stranded DNA: sequence-speciﬁc suicide transcription. Nucleic Acids Res., 24, 458–463. 66. Morris,K.V. (2009) RNA-directed transcriptional gene silencing and activation in human cells. Oligonucleotides, 19, 299–306.